Significant Ownership of Ph.D. John P. McKearn
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Ph.D. John P. McKearn focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager location
- San Diego, CA
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
1 identity field
Follow Filing Activity
Follow Ph.D. John P. McKearn and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
CIK context first
Continue from Ph.D. John P. McKearn
Significant Ownership of Ph.D. John P. McKearn
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| SPRB | SPRUCE BIOSCIENCES, INC. | Common Stock, par value $0.001 per share | 4.2% | $140,762 | 1,759,521 | John P. McKearn, Ph.D. | 07 Jan 2025 | ||
| RPHM | OnKure Therapeutics, Inc. | Common Stock, par value $0.0001 per share | 1.6% | $333,517 | 196,198 | John P. McKearn, Ph.D. | 16 Jan 2025 |
Schedules 13D/G Reported by Ph.D. John P. McKearn:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.